SC
Stempoint Capital Portfolio holdings
AUM
$496M
1-Year Est. Return
93.41%
1 Year Est. Return
+93.41%
AUM
$496M
AUM Growth
+$185M
(+60%)
Holding
92
Top Buys
| 1 | +$54.4M | |
| 2 | +$14.9M | |
| 3 | +$12.6M | |
| 4 |
argenx
ARGX
|
+$9.19M |
| 5 |
Wave Life Sciences
WVE
|
+$8.86M |
Top Sells
| 1 | +$20.4M | |
| 2 | +$18M | |
| 3 | +$15.6M | |
| 4 |
Syndax Pharmaceuticals
SNDX
|
+$15.5M |
| 5 |
CNTA
Centessa Pharmaceuticals
CNTA
|
+$14.8M |
Sector Composition
| 1 | Healthcare | 99.22% |
| 2 | Financials | 0.32% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1
Roivant Sciences
ROIV
$14.4B
| $63.5M | 12.72% |
4,197,187
+3,595,406
|
|
||
2
uniQure
QURE
$1.59B
| $30.5M | 6.11% |
522,155
-50,460
|
|
||
3
Scholar Rock
SRRK
$4.44B
| $27M | 5.42% |
726,204
+198,089
|
|
||
4
Immunovant
IMVT
$3.98B
| $25.6M | 5.13% |
1,589,580
+288,720
|
|
||
5
Denali Therapeutics
DNLI
$2.79B
| $25.2M | 5.05% |
1,734,659
+1,026,744
|
|
||
|
6
Syndax Pharmaceuticals
SNDX
$1.71B
| $21M | 4.21% |
1,366,205
-1,006,429
|
|
||
|
CNTA
7
Centessa Pharmaceuticals
CNTA
$4.3B
| $15.9M | 3.18% |
655,385
-610,287
|
|
||
|
8
Wave Life Sciences
WVE
$1.19B
| $15.4M | 3.09% |
2,110,152
+1,209,814
|
|
||
9
Biohaven
BHVN
$1.21B
| $15.3M | 3.06% |
1,017,311
+842,557
|
|
||
10
Cidara Therapeutics
CDTX
$6.95B
| $14.6M | 2.92% |
152,325
-114,449
|
|
||
|
ABVX
11
Abivax
ABVX
$8.64B
| $14.1M | 2.83% |
166,273
+78,525
|
|
||
12
IDEAYA Biosciences
IDYA
$3.01B
| $10.1M | 2.03% |
371,825
+205,940
|
|
||
13
Rhythm Pharmaceuticals
RYTM
$6.98B
| $9.23M | 1.85% |
91,444
-85,308
|
|
||
|
14
argenx
ARGX
$56.8B
| $9.19M | 1.84% |
+12,465
|
|
||
15
Surrozen
SRZN
$135M
| $9.19M | 1.84% |
713,463
+26,924
|
|
||
16
Revolution Medicines
RVMD
$15B
| $8.66M | 1.73% |
+185,380
|
|
||
17
Rezolute
RZLT
$878M
| $8.63M | 1.73% |
917,630
+272,976
|
|
||
18
GH Research
GHRS
$892M
| $7.8M | 1.56% |
545,275
+444,449
|
|
||
19
Arcutis Biotherapeutics
ARQT
$3.67B
| $7.76M | 1.56% |
411,893
+206,221
|
|
||
20
VistaGen Therapeutics
VTGN
$147M
| $7.75M | 1.55% |
2,488,685
+75,431
|
|
||
21
Xenon Pharmaceuticals
XENE
$3.42B
| $7.72M | 1.55% |
+192,295
|
|
||
22
Alkermes
ALKS
$4.88B
| $7.25M | 1.45% |
241,637
-109,487
|
|
||
23
Celcuity
CELC
$4.63B
| $6.75M | 1.35% |
+136,710
|
|
||
24
BridgeBio Pharma
BBIO
$14.3B
| $6.62M | 1.33% |
127,435
+72,805
|
|
||
25
Insmed
INSM
$44.1B
| $6.25M | 1.25% |
43,419
-18,159
|
|